These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 24819665

  • 1. Epidermal growth factor receptor (EGFR) pathway genes and interstitial lung disease: an association study.
    Li C, Wei R, Jones-Hall YL, Vittal R, Zhang M, Liu W.
    Sci Rep; 2014 May 13; 4():4893. PubMed ID: 24819665
    [Abstract] [Full Text] [Related]

  • 2. EGF+61 A>G polymorphism is not associated with lung cancer risk in the Brazilian population.
    Laus AC, de Paula FE, de Lima MA, Carlos CD, Gomes INF, de Marchi P, Valente JKN, Pioltini ABM, Miziara JE, da Silva CM, Viana LS, Scapulatempo-Neto C, Reis RM.
    Mol Biol Rep; 2019 Apr 13; 46(2):2417-2425. PubMed ID: 30783937
    [Abstract] [Full Text] [Related]

  • 3. Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease.
    Stock CJW, De Lauretis A, Visca D, Daccord C, Kokosi M, Kouranos V, Margaritopoulos G, George PM, Molyneaux PL, Nihtyanova S, Chua F, Maher TM, Ong V, Abraham DJ, Denton CP, Wells AU, Wain LV, Renzoni EA.
    Clin Rheumatol; 2020 Apr 13; 39(4):1173-1179. PubMed ID: 31916109
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Analysis of polymorphisms in EGF, EGFR and HER2 genes in pancreatic neuroendocrine tumors (PNETs).
    Marinović S, Cigrovski Berković M, Zjačić-Rotkvić V, Kapitanović S.
    Cancer Genet; 2022 Aug 13; 266-267():44-50. PubMed ID: 35777127
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patients.
    Leal LF, Laus AC, Cavagna R, de Paula FE, de Oliveira MA, Ribeiro DM, Hassan FM, Miziara JE, da Silva ECA, da Silva VD, De Marchi P, Reis RM.
    Thorac Cancer; 2020 Oct 13; 11(10):2987-2992. PubMed ID: 32881389
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study.
    de Mello RA, Ferreira M, Costa S, Costa BM, Pires FS, Neves I, Almeida MI, Cunha J, Oliveira P, Hespanhol V, Reis RM.
    Tumour Biol; 2012 Oct 13; 33(5):1341-8. PubMed ID: 22457050
    [Abstract] [Full Text] [Related]

  • 11. EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.
    Piao Y, Liu Z, Ding Z, Xu L, Guo F, Sun Q, Xie X.
    Gene; 2013 Apr 25; 519(1):26-33. PubMed ID: 23403233
    [Abstract] [Full Text] [Related]

  • 12. Positive Association between ANKRD55 Polymorphism 7731626 and Dermatomyositis/Polymyositis with Interstitial Lung Disease in Chinese Han Population.
    Li L, Chen S, Wen X, Wang Q, Lv G, Li J, Yang F, Zhang F, Li Y.
    Biomed Res Int; 2017 Apr 25; 2017():2905987. PubMed ID: 28470010
    [Abstract] [Full Text] [Related]

  • 13. Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes.
    Wei R, Li C, Zhang M, Jones-Hall YL, Myers JL, Noth I, Liu W.
    Transl Res; 2014 May 25; 163(5):494-502. PubMed ID: 24434656
    [Abstract] [Full Text] [Related]

  • 14. Preexisting interstitial lung disease is inversely correlated to tumor epidermal growth factor receptor mutation in patients with lung adenocarcinoma.
    Fujimoto D, Tomii K, Otoshi T, Kawamura T, Tamai K, Takeshita J, Tanaka K, Matsumoto T, Monden K, Nagata K, Otsuka K, Nakagawa A, Hata A, Tachikawa R, Otsuka K, Hamakawa H, Katakami N, Takahashi Y, Imai Y.
    Lung Cancer; 2013 May 25; 80(2):159-64. PubMed ID: 23419507
    [Abstract] [Full Text] [Related]

  • 15. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) POLYMORPHIC VARIATIONS (-216G/T & -191 C/A) POSE A HIGH RISK TO PATIENTS WITH MALIGNANT GLIOMA.
    Zahoor W, Pandith AA, Nisar S, Qasim I, Surana M, Ganie FA, Manzoor U, Arif SH, Rasool SUA, Lateef A, Shah P, Bhat RA.
    Exp Oncol; 2023 Oct 11; 45(2):203-210. PubMed ID: 37824771
    [Abstract] [Full Text] [Related]

  • 16. The Association between Epidermal Growth Factor Receptor (EGFR) Gene Polymorphisms and Lung Cancer Risk.
    Bashir NA, Ragab ES, Khabour OF, Khassawneh BY, Alfaqih MA, Momani JA.
    Biomolecules; 2018 Jul 13; 8(3):. PubMed ID: 30011810
    [Abstract] [Full Text] [Related]

  • 17. Association between epidermal growth factor receptor gene polymorphisms and susceptibility to Parkinson's disease.
    Jin J, Xue L, Bai X, Zhang X, Tian Q, Xie A.
    Neurosci Lett; 2020 Sep 25; 736():135273. PubMed ID: 32712352
    [Abstract] [Full Text] [Related]

  • 18. The association of epidermal growth factor variant with oral squamous cell carcinoma.
    Ertugrul B, Mohammed A, Kasarci G, Bireller S, Ulusan M, Cakmakoglu B.
    Environ Mol Mutagen; 2023 Sep 25; 64(8-9):473-479. PubMed ID: 37658772
    [Abstract] [Full Text] [Related]

  • 19. Association of Epidermal Growth Factor 61A>G, Survivin -31G>C, and EFNA1 -1732G>A Polymorphisms with Susceptibility to Colorectal Cancer.
    Asadian F, Ghadyani M, Antikchi MH, Dastgheib SA, Neamatzadeh H, Sheikhpour E, Khajehnoori S, Tabei SS.
    J Gastrointest Cancer; 2022 Mar 25; 53(1):78-83. PubMed ID: 33180239
    [Abstract] [Full Text] [Related]

  • 20. Effect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population.
    Daraei A, Salehi R, Salehi M, Emami MH, Janghorbani M, Mohamadhashem F, Tavakoli H.
    Med Oncol; 2012 Jun 25; 29(2):1044-9. PubMed ID: 21567271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.